Prescribing benzodiazepines in general practice: a new view of an old problem

Abstract

General practitioner (GP) prescribing has been identified as an arena that has broad social and political implications, which stretch beyond individual outcomes for patients. This article revisits aspects of the controversy about prescribing benzodiazepines (or ‘minor tranquillizers’) through an exploration of contemporary views of GPs. In the 1980s the prescribing of these drugs was considered to be both a clinical and social problem, which brought medical decision making under public scrutiny. The legacy of this controversy for recent GPs remains a relatively under-explored topic. This article describes a qualitative study of GPs practising in the north-west of England about their views of prescribing benzodiazepines. The accounts of the respondents highlight a number of points about: blame allocation, past and present; clinical challenges about risk management; and deserving and undeserving patients. These GP views are then discussed in the wider context of psychotropic drug use. It is concluded that, while there has been a recent consensus that the benzodiazepines have been problematic, when they are placed in a longer historical context, a different picture is apparent because other psychotropic drugs have raised similar problems.

Keywords

benzodiazepines GPs' perspectives narratives psychotropic medication

Get full access to this article

View all access options for this article.

References

Baldessarini, R.J. (1999). Psychopharmacology. In A.M. Nicholi (Ed.), The Harvard guide to psychiatry, pp. 76–98. Harvard: Belknap.

Beck, U. (1992). The risk society: Towards a new modernity. London: Sage.

Breggin, P. (1993). Toxic psychiatry. London: HarperCollins.

Britten, N. , Stevenson, F. , Gafaranga, J. , Barry, C. and Bradley, C. (2004). The expression of aversion to medicines in general practice consultations. Social Science & Medicine, 59(7), 1495–1503.

Brown, P. and Funk, S.C. (1986). Tardive dyskinesia: Barriers to the professional recognition of iatrogenic disease. Journal of Health and Social Behavior, 27(2), 116–132.

Bury, M. and Gabe, J. (1990). Hooked? Media responses to tranquillizer dependence. In P. Abbott and G. Payne (Eds.), New directions in the sociology of health, pp. 87–103. London: Falmer Press.

Cohen, S. (1983). Current attitudes about the benzodiazepines: Trial by media. Journal of Psychoactive Drugs, 15(1–2), 109–113.

Committee on the Safety of Medicines . (1988). Benzodiazepines, dependence and withdrawal symptoms. Current Problems, 21.

Cooperstock, R. (1978). Sex differences in psychotropic drug use. Social Science and Medicine, 1(12), 179–186.

10.

Fisher, S. and Greenberg, R.P. , Eds. (1997). From placebo to panacea: Putting psychiatric drugs to the test. New York: Wiley.

11.

Gabe, J. and Thorogood, N. (1986). Prescribed drug use and the management of everyday life: The experience of white working class women. Sociological Review, 34(4), 737–772.

12.

Giddens, A. (1991). Modernity and self identity: Self and society in the late modern age. Cambridge: Polity.

13.

Hamilton, I.J. , Reay, L.M. and Sullivan, F.M. (1990). A survey of general practitioners' attitudes to benzodiazepine overprescribing. Health Bulletin, 48(6), 299–303.

14.

Healy, D. (1997). The anti-depressant era. London: Harvard University Press.

15.

Jeffries, R. (1979). ‘Normal rubbish’: Deviant patients in casualty departments. Sociology of Health and Illness, 1(1), 90–109.

16.

Lacey, R. (1991). The MIND complete guide to psychiatric drugs. London: MIND.

17.

Lader, M. , Beaumont, G. and Bond, A. (1992). Guidelines for the management of patients with generalized anxiety. Psychiatric Bulletin, 16, 560–565.

18.

Lester, H.E. , Tritter, J.Q. and Sorohan, H. (2005). Patients' and health professionals' views on primary care for people with serious mental illness: Focus group study. British Medical Journal, 330, 1126–1126B.

19.

May, C. , Allison, G. , Chapple, A. , Chew-Graham, C. , Dixon, C. , Gask, L. et al. (2004). Framing the doctor–patient relationship in chronic illness: A comparative study of general practitioners' accounts. Sociology of Health & Illness, 26(2), 135–158.

20.

Medawar, C. (1992). Power and dependence. London: Social Audit.

21.

Moncrieff, J. and Crawford, M.J. (2001). British psychiatry in the 20th century: Observations from a psychiatric journal. Social Science & Medicine, 53(3), 349–356.

22.

Moncrieff, J. , Hopker, S. and Thomas, P. (2005). Psychiatry and the pharmaceutical industry. Psychiatric Bulletin, 29, 84–85.

23.

North, D. , Davis, P. and Power, A. (1995). Patient responses to benzodiazepine medication: A typology of adaptive repertoires developed by long-term users. Sociology of Health & Illness, 17(5), 632–650.

24.

Olson, M. and Pincus, H. (1994). Use of benzodiazepines in the community. Archives of Internal Medicine, 154(11), 1235–1240.

25.

Parr, J.M. , Kavanagh, D.J. , Young, R.M. and McCafferty, K. (2006). Views of general practitioners and benzodiazepine users on benzodiazepines: A qualitative analysis. Social Science & Medicine, 62(5), 1237–1244.

26.

Rogers, A. and Pilgrim D. (2001). Mental health policy in Britain. Basingstoke: Palgrave.

27.

Stevenson, F.A. , Britten, N. , Barry, C.A. , Bardley, C.P. and Barber, N. (2002). Perceptions of legitimacy: The infl uence on medicine taking and prescribing. Health: 6(1), 85–104.

28.

Stimson, G. and Webb, B. (1975). Going to see the doctor: The consultation process in general practice. London: Routledge & Kegan Paul.

29.

Swartz, M.S. , Swanson, J. , Hiday, V.A. , Borum, R. , Wagner, R. and Burns, B.J. (1998). Taking the wrong drugs: The role of substance abuse and medication noncompliance in violence among severely mentally ill individuals. Social Psychiatry and Psychiatric Epidemiology, 33(Supp. 1), S75–S80.

30.

Turner, B.S. (1991). Recent developments in the theory of the body. In M. Featherstone , M. Hepworth and B.S. Turner (Eds.), The body: Social processes and cultural theory, pp. 1–35. London: Sage.

31.

Tyrer, P. (1987). Benefits and risks of benzodiazepines. Proceedings of the Royal Society of Medicines, 114, 7–11.

32.

Tyrer, P. , Harrison-Read, P. and van Horn, E. (1997). Drug treatment in psychiatry. London: Butterworth Heineman.